Skip to main content
. 2021 Apr 22;16(4):e0250351. doi: 10.1371/journal.pone.0250351

Table 4. In vitro digestibility using the DaisyII Incubator and according to the method described in Hervera et al. [38], (HV-IVD) and in Biagi et al. [39], (BG-IVD).

Step HV-IVD BG-IVD
0.5 ± 0.01 g of sample1 0.5 ± 0.01 g of sample
1 Gastric digestion 1200 ml phosphate buffer
(0.1M, pH 6)
480 ml HCl (0.2M)
480 mg pepsin
24 ml cloramphenicol solution
(0.5g/100 ml ethanol)
pH 2, 39°C, 2 h
1440 ml of pepsin-lipase-HCl solution
(HCl 0.075N; pepsin 2g/L; gastric lipase 1g/L)
39°C, 2 h
2 Post-gastric digestion 480 ml phosphate buffer
(0.2 M, pH 6.8)
240 ml NaOH (0.6 M)
4.8 g pancreatin
pH 6.8, 39°C, 4 h
1440 ml -pancreatin-bile salt-phosphate buffer solution
(10g/L pancreatin 25 g/L; bile salt)
pH 7.5, 39°C, 4 h
3 Collection of undigested fraction F57 washed, twiced with ethanol (96%) and twice with acetone (99%), dried overnight at 70°C, analysed for CP, EE, DM, OM F57 washed, dried overnight at 65°C, analysed for CP, EE, DM, OM

1 Quantities for each jar and twenty-four F57 filter bags (twenty-three replicate samples and one blank).